Companies /Healthcare

Merck & Co Inc

NYSE: MRK Drug Manufacturers - General
$150.92
▼ $2.18 (−1.42%) today
Markets open · 1:19pm ET

MRK Coverage

Page 73
1:15pm ET
Health and Healthcare

Merck (MRK) Losing Out On OTC?

If a company like Merck (MRK) is going to overcome problems with a lot its drugs going "off patent" it is going to have to come up with some new ways to…

MRK
Douglas A. McIntyre
9:32am ET
Investing

Merck (MRK) Estimates Miss Street

Merck (MRK) is not going to do as well as Wall St. had hoped next year. It guided to $3.28 to $3.38 earnings per share. A Reuters poll puts the number at…

MRK
Douglas A. McIntyre
8:29am ET
Investing

Pre-Market Stock News (November 9, 2007)

Allscripts (MDRX) traded down 25% after missing earnings estimates and after lower guidance for 2007 and 2008. American Tower (AMT) replacing Alltel (AT) in S&P. ARM Holdings plc (ARMHY) trading down about…

Douglas A. McIntyre
6:13am ET
Health and Healthcare

Vioxx: Merck (MRK) Settled Too Early, Much Too Early

It has been a bloody and bitter fight. Merck’s (MRK) pain killer Vioxx has been alleged to cause heart problems and worse. The drug hit the market in 1999 and was pulled…

MRK
Douglas A. McIntyre
8:37am ET
Health and Healthcare

GTX Soaring On Merck Collaboration (GTXI, MRK)

GTx, Inc. (NASDAQ: GTXI) is seeing shares trade sharply higher on a collaboration pact with Merck (NYSE: MRK).  The biotech and drug giant pact is for research and development and a strategic…

MRK
Douglas A. McIntyre
6:49am ET
Investing

Merck (MRK) Comes Through

Merck (MRK) announced third-quarter 2007 earnings per share of $0.75, excluding restructuring charges, and third-quarter reported EPS of $0.70. Worldwide sales were $6.1 billion for the quarter, an increase of 12 percent…

MRK
Douglas A. McIntyre